Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Regeneron, Sanofi Announce Phase 3 Results for Praluent Study in Japan

July 10, 2015 8:58 am | News | Comments

The study showed LDL-C reductions of more than 60 percent in the test group. Read more...

TOPICS:

Research to Unlock Study Doping Facts

July 10, 2015 8:48 am | by University of Queensland | News | Comments

The study aims to capture Australian university students’ attitudes towards and experiences with taking prescription drugs to try and improve study sessions. Read more...

TOPICS:

New Guidelines for Treating Diabetic Retinal Degeneration

July 10, 2015 8:41 am | by Medical University of Vienna | News | Comments

Around 600,000 Austrians suffer from diabetes. This condition is frequently associated with serious retinal disorders. Read more...

TOPICS:
Advertisement

AstraZeneca, Ironwood Announce Positive Phase 3 Linaclotide Trial Results in China

July 10, 2015 8:41 am | News | Comments

Full results from the trial are expected to be submitted for presentation at an upcoming medical congress. Read more...

TOPICS:

Bacterial Computing

July 10, 2015 8:40 am | by MIT | News | Comments

The team developed a series of genetic parts that can be used to precisely program gene expression within the bacteria. Read more...

TOPICS:

Scientists Exaggerate Results Without Blind Trials, Study Claims

July 10, 2015 8:40 am | by Seth Augenstein, Digital Reporter | News | Comments

An inherent bias can color scientific results when researchers can see which samples they’re testing, according to a review of 900,000 experiments by a group of Australian biologists. Read more...

TOPICS:

University of South Florida Sues Drug Maker Over Research Patent Payment

July 9, 2015 1:41 pm | by Seth Augenstein, Digital Reporter | News | Comments

The University of South Florida filed a federal lawsuit against a California pharmaceutical company, over a 2012 settlement agreement ending a large lawsuit over Alzheimer’s research patents. Read more...

TOPICS:

Aridis Expands Trial into the U.S. for Pneumonia Treatment

July 9, 2015 12:58 pm | News | Comments

Aridis Pharmaceuticals, Inc., a biopharmaceutical company applying proprietary technologies to produce novel anti-infectives and immunotherapies for infectious diseases, announced today that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for AR-301, also referred to as Salvecin. Read more...

TOPICS:
Advertisement

Designed Drug Candidate Significantly Reduces HIV Reactivation Rate

July 9, 2015 12:55 pm | by Scripps Research Institute | News | Comments

HIV-infected patients remain on antiretroviral therapy for life because the virus survives over the long-term in infected dormant cells. Interruption of current types of antiretroviral therapy results in a rebound of the virus and clinical progression to AIDS. Read more...

TOPICS:

Johnson & Johnson: Drug Clears More Psoriasis Than Rival's

July 9, 2015 12:48 pm | by Linda A. Johnson, AP Business Writer | News | Comments

A study funded by drugmaker Johnson & Johnson indicates its experimental psoriasis medicine works better than a rival drug that dominates the market for biologic drugs for immune disorders. Read more...

TOPICS:

PD-1 and PD-L1 Recombinant Cell Lines

July 9, 2015 11:09 am | by Crown Bioscience | Product Releases | Comments

Crown Bioscience now offers recombinant PD-1 and PD-L1 cell lines for drug screening and biological assays. These HEK 293T cell lines stably express exogenous human PD-1 or PD-L1, and are ideal for screening PD-1 and PD-L1 antibody drugs and/or inhibitors.

Can Vaccination, Diagnostics Help to Combat Antibiotic Resistance?

July 9, 2015 9:13 am | by Stephanie Guzowski, Editor | Articles | Comments

Resistance to antibiotics and other antimicrobials is growing worldwide, with deaths from resistant infections at about 700,000 per year, and estimated to rise to 10 million per year by 2050. Leaders in government and industry have prompted the question: Could strategic development and use of novel vaccines prolong the life span of antibiotics in the pipeline? Read more...

TOPICS:

Theranos Gains FDA Approval for New Blood-based Herpes Test

July 9, 2015 9:05 am | by Ryan Bushey, Associate Editor | Articles | Comments

The team at Theranos plans on submitting more lab-developed tests (LDTs) for the agency to review. Read more...

TOPICS:

How Insulin Calms Brain Activity

July 9, 2015 8:44 am | by McGill University | News | Comments

Insulin has long been known as the hormone which controls the body’s sugar levels: humans who lack or are insensitive to insulin develop diabetes. Read more...

TOPICS:

Mylan Launches First Generic Targretin Capsules

July 9, 2015 8:37 am | News | Comments

Bexarotene 75mg Capsules had U.S. sales of approximately $155.5 million for the 12 months ending March 31, 2015, according to IMS Health. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading